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Purpose: The aim of this study was to evaluate whether long-term, postoperative ure-
teral stenting is necessary after ureteroscopic removal of stones (URS) during an un-
complicated surgical procedure. 
Materials and Methods: We prospectively examined 54 patients who underwent URS 
for lower ureteral stones from February 2010 to October 2010. Inclusion criteria were 
a stone less than 10 mm in diameter, absence of ureteral stricture, and absence of ureter-
al injury during surgery. We randomly placed 5 Fr. open-tip ureteral catheters in 26 
patients and removed the Foley catheter at postoperative day 1. The remaining 28 pa-
tients received double-J stents that were removed at postoperative day 14 by cystoscopy 
under local anesthesia. All patients provided visual analogue scale (VAS) pain scores 
at postoperative days 1, 7, and 14 and completed the storage categories of the 
International Prostate Symptom Score (IPSS) at postoperative day 7. 
Results: The VAS scores were not significantly different on postoperative day 1 but were 
significantly smaller in the 1-day ureteral catheter group at postoperative days 7 and 
14 (p＜0.01). All of the storage categories of the IPSS were significantly lower in the 
1-day ureteral stent group (p＜0.01). The ratio of patients who needed intravenous an-
algesics because of severe postoperative flank pain was not significantly different be-
tween the two groups (p=0.81). No patients experienced severe flank pain after post-
operative day 2, and no patients in either group had any other complications.
Conclusions: One-day ureteral catheter placement after URS can reduce postoperative 
pain and did not cause specific complications compared with conventional double-J 
stent placement.
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The double-J stent was first described by Finney et al in 
1978 [1,2]. Since then, ureteral stents have been conven-
tionally placed to reduce the occurrence of colicky pain due 
to ureteral stricture and the ureteral edema that can occur 
following ureteroscopic removal of stones (URS) [3,4]. 
There are also reports that the placement of an indwelling 
ureteral stent following URS prevents or reduces the occur-
rence of ureteral stricture [5]. However, indwelling stents 
can cause symptoms such as hematuria, dysuria, flank 
pain, and frequency. In addition, other problems could re-
quire a ureteral stent to be removed by use of a cystoscope. 
With the recent development of a smaller caliber uretero-
scope, the occurrence of iatrogenic ureteral injury has de-
creased and the frequency of ureteral orifice dilation has 
been reduced. Accordingly, there are also reports of proce-
dures in which ureteral stents are not conventionally Korean J Urol 2011;52:698-702
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placed. In cases with a lack of complications (such as ureter-
al injury or ureteral orifice stricture), ureteral stones can 
be safely removed without postoperatively leaving a ure-
teral stent indwelling following URS. In addition, it has al-
so been reported that postoperative symptoms associated 
with ureteral stents could be shortened [6]. Djaladat et al 
equally divided 109 patients who underwent URS into two 
groups: patients who received a 5 Fr. polyurethane ureteral 
catheter left indwelling for 24 hours (n=54) and a noncathe-
terized group (n=55) [7]. They reported that flank pain and 
renal colic on the first postoperative day were significantly 
higher in the noncatheterized group. This flank pain and 
renal colic resulted from early ureteral edema; having a 
ureteral catheter for the first 24 hours seemed to eliminate 
the possibility of early ureteral edema, secondary hydro-
nephrosis, and pain. Hosking et al reported that mild flank 
pain could occur in 57% of patients unless a ureteral stent 
was left indwelling following URS [6]. Because the pain 
usually disappears within 48 hours postoperatively, how-
ever, the pain might occur temporarily because of ureteral 
edema. To date, no Korean studies have reported on 
short-term, indwelling ureteral catheter use following 
URS for lower ureteral stones.
　We conducted this prospective study to assess the effi-
cacy and safety of a 1-day indwelling period of an open- 
ended ureteral catheter following URS for lower ureteral 
stones compared with the long-term indwelling of a con-
ventional type of ureteral catheter. 
MATERIALS AND METHODS
1. Participants and study design
The present study was conducted in patients who under-
went URS for ureteral stones during the period between 
February and October of 2010 at two hospitals in Korea. 
Inclusion criteria were 1) lower ureteral stones and 2) at 
least one stone smaller than 10 mm in diameter. Exclusion 
criteria included 1) patients who were indicated for shock 
wave lithotripsy for the presence of renal stones on the ipsi-
lateral side, 2) patients who underwent a ureteral opening 
dilation for the presence of ureteral opening stricture, and 
3) patients who suffered ureteral mucosal injury during the 
surgery. The locations and sizes of the ureteral stones were 
assessed by preoperative computerized tomography.
　The current prospective study was conducted in 54 
patients. Of these patients, 26 were randomly selected by 
using a random function of Open Office Calc (Open Office. 
org
Ⓡ version 3.2.0, Oracle Corp., Redwood Shores, CA, 
USA), and these patients received a 5 Fr. open-ended ure-
teral catheter that was placed for 1 day following surgery. 
Then, the catheter was exposed ex vivo and fixed by using 
a rubber band along with a urethral Foley catheter. The 
catheter was sealed with a surgical glove and then drained 
(group 1). In the remaining 28 patients, a 5 Fr. double-J 
stent was placed for 2 weeks postoperatively (group 2). The 
length of the double-J stent varied depending on the height 
of the patient, and it ranged between 22 and 26 cm.
　All patients underwent surgery under spinal epidural 
anesthesia. Surgery was done by using an 8.5-Fr. rigid ure-
teroscope (Karl Storz
Ⓡ, Tuttlingen, Germany). Ureteral 
stones were fragmented by using a Holmium:YAG laser 
with an energy of 3 J (0.6 Hz, 5 W). The excretion of the frag-
mented ureteral stones was monitored by using a stone 
basket. In patients who had an indwelling, 5-Fr. open- 
ended ureteral catheter, this catheter was removed along 
with the urethral Foley catheter on postoperative day 1. 
Patients who had an indwelling, double-J stent also re-
ceived local anesthesia using 1% lidocaine gel for the ure-
thra during postoperative week 2, and the double-J stent 
was removed by using a cystoscope.
　The operation time of URS was defined as the length of 
time that elapsed from the time the ureteroscope entered 
the urethral opening until all the endoscopes were 
removed. To compare the subjective degree of pain, all pa-
tients were asked to complete a visual analogue scale (VAS) 
pain score on postoperative day 1 and at weeks 1 and 2. In 
addition, patients who had an indwelling double-J stent 
were asked to complete a VAS immediately after the re-
moval of the cystoscopic stent. To monitor changes in irrita-
tive bladder symptoms due to the use of a double-J stent, 
all patients completed a questionnaire about storage 
symptoms on the International Prostate Symptom Score 
(IPSS) at postoperative week 1. To compare the degree of 
satisfaction with postoperative outcomes, participants 
were asked the following question: “Are you willing to un-
dergo the same surgery if you experience ureteral stones 
again?” on postoperative week 2. Patients responded with 
either “Yes” or “No.” 
2. Assessment of pain and safety
To quantitatively assess the patients’ pain, the severity of 
pain was graded on an 11-point scale by using the VAS 
(where 0 points=no pain and 10 points=the most severe 
pain). Postoperative complications, such as fever and hem-
aturia, were evaluated during the hospitalization period 
and at postoperative weeks 1 and 2 in an outpatient setting. 
To unify the type and amount of analgesics administered 
for patients who complained of flank pain, patients were 
first given an intravenous injection of tramadol 50 mg. 
Thereafter, if the pain was persistent, patients received an 
intravenous injection of pethidine 25 mg. All patients were 
examined for residual stones by plain X-ray at post-
operative day 1 and via intravenous pyelography at 4 
weeks postoperatively to identify any occurrence of ureter-
al stricture. The patients were also asked to visit the out-
patient clinic at postoperative month 3 to monitor any re-
currence of flank pain. 
3. Statistical analysis
A comparative analysis was performed to evaluate the age, 
gender, ureteral stone size, and operative time between the 
two groups by using Student’s t-tests and Pearson chi- 
square tests. We also comparatively analyzed our results 
to evaluate the severity of pain at postoperative day 1 and Korean J Urol 2011;52:698-702
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FIG. 1.  Visual Analogue Scale score over time. Group 1: 5 Fr 
ureteral catheter placement for 1 day, Group 2: 5 Fr double-J 
ureteral stent placement for 14 days. 
a: Student’s independent 
t-test




No. of patients 26 28
Age   44.38±13.05   50.76±11.91 0.84
c
Sex (male:female) 14:12 19:9 0.29
d
Size of stone (mm)   6.03±1.18   6.46±1.40 0.10
c
Operative time (min) 25.00±8.00 26.25±8.23 0.65
c
a: 5 Fr ureteral catheter placement for 1 day, 
b: 5 Fr double-J ureter-
al stent placement for 14 days, 
c: Student’s independent t-test, 
d:
Chi-square test
TABLE 2. Comparison of storage symptoms between the two 




IPSS frequency 0.15±0.46 1.17±0.94 ＜0.01
IPSS urgency 0.07±0.27 0.71±0.76 ＜0.01
IPSS nocturia 0.07±0.27 0.39±0.68 ＜0.01
IPSS sum of storage 0.30±0.73 2.28±1.41 ＜0.01
  symptom
IPSS: International Prostate Symptom Score, 
a: 5 Fr ureteral 
catheter placement for 1 day, 
b: 5 Fr double-J ureteral stent place-
ment for 14 days
TABLE 3. Comparison of colicky pain attacks and willingness to 





c (%)   4 (15.4)   5 (17.9) 0.55
d
Willingness to undergo 23 (88.5) 17 (60.7) 0.02
e
 the same procedure (%)
a: 5 Fr ureteral catheter placement for 1 day, 
b: 5 Fr double-J ureter-
al stent placement for 14 days, 
c: Severe pain: pain required intra-
venous analgesics (tramadol or mepedrine), 
d: Fisher's exact test,
e: Chi-square test
weeks 1 and 2, and the scores for each category regarding 
storage symptoms of the IPSS and total scores at post-
operative week 1.
　We used Fisher’s exact tests and Pearson chi-square 
tests to compare the number of patients who needed intra-
venous analgesics due to severe postoperative pain and al-
so to examine the responses to our questionnaire: “Are you 
willing to undergo the same surgery if you experience ure-
teral stones again?”
RESULTS
Age, gender, ureteral stone size, and operative time were 
not significantly different between the two groups (Table 
1).
On postoperative day 1, the mean VAS scores for flank 
pain in group 1 and group 2 were 2.53±1.94 and 3.14±1.84, 
respectively, which were not significantly different (p= 
0.55). At postoperative week 1, however, the mean VAS 
scores for flank pain were 0.19±0.49 in group 1 and 2.60± 
0.87 in group 2. These scores were significantly different 
between the groups (p＜0.01). Additionally, the mean VAS 
scores for flank pain at postoperative week 2 were 0.07± 
0.27 for group 1 and 2.50±1.10 in group 2. This finding was 
also significantly different between the two groups (p
＜0.01) (Fig. 1). We calculated the mean VAS to assess the 
severity of pain during the removal of a cystoscopic ureteral 
catheter under local anesthesia in group 2, and its mean 
value was 4.96±1.29. This finding corresponded to a moder-
ate severity of pain.
　On postoperative week 1, the IPSS values for frequency, 
urgency, and nocturia were significantly different between 
group 1 and group 2 (p＜0.01) (Table 2). In four group 1 pa-
tients, tramadol 50 mg was injected on postoperative day 
1 because the patients reported severe pain. Three group 
1 patients who experienced persistent pain received an in-
jection of pethidine 25 mg. In group 2, five patients were 
given tramadol 50 mg injections for severe pain on post-
operative day 1. Two additional group 2 patients who had 
persistent pain received pethidine 25 mg injections. No pa-
tients complained of pain with severity so great as to need 
analgesics after postoperative day 2. In addition, there 
were no complications such as postoperative fever or severe 
hematuria. Four patients in group 1 and five patients from 
group 2 (15.4% and 17.9%, respectively; p=0.81) received 
postoperative intravenous injections of analgesics (Table 
3). No patients in either group had residual stones or ure-
teral stricture on intravenous pyelography at the 4-week 
follow-up visit. At postoperative month 3, no patients re-
ported recurring flank pain, and no other complications 
were observed in either group. 
　At postoperative week 2, a total of 23 patients in group 
1 and 17 patients in group 2 responded that they would un-
dergo the procedure again if necessary. Accordingly, the Korean J Urol 2011;52:698-702
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possibility that surgery could be repeated again with the 
same methods was 88.5% and 60.7% in the two groups, re-
spectively, with a relatively higher chance in group 1 
(p=0.02) (Table 3).
DISCUSSION
Ureteral stenting is traditionally used to treat ureteral 
strictures and ureteral obstruction, and it is also fre-
quently recommended to prevent the occurrence of flank 
pain and ureteral stricture following URS [4,8,9]. 
According to Stoller et al however, ureteral stent-related 
symptoms, such as flank pain, frequency, urgency, and 
dysuria, manifest in only 50% of patients who receive an 
indwelling ureteral stent [8]. In addition, Bregg and 
Riehle?also reported that ureteral catheter-related com-
plications, such as gross hematuria (42%), dysuria (26%), 
and flank pain (30%), appear before the shock wave litho-
tripsy in 50 patients with an indwelling ureteral catheter 
[10]. Pollard and Macfarlane found that ureteral stent-re-
lated symptoms appeared in 18 (90%) of 20 patients who 
had indwelling ureteral stents following URS [11]. Han et 
al also reported time-dependent changes in symptoms in 
patients who had received indwelling, double-J ureteral 
stents [12]. According to these authors, hematuria was the 
most common symptom (69.5%) of all symptoms evaluated 
at 1 week after placement of an indwelling ureteral stent, 
followed by dysuria (45.8%), frequency (42.2%), lower ab-
dominal pain during voiding (32.2%), and flank pain 
(25.4%). Except for urgency, most of the symptoms showed 
no significant time-dependent differences until ureteral 
stent removal.
　Additionally, in the current study, patients who had an 
indwelling double-J stent for 2 weeks following URS expe-
rienced a mean VAS score for flank pain of 2.60±0.87 points 
at postoperative week 1 and 2.5±1.10 points at post-
operative week 2. IPSS values for frequency, urgency, and 
nocturia were relatively higher in patients who had an in-
dwelling double-J ureteral catheter for 2 weeks than they 
were in those who had an indwelling of an open-ended ure-
teral catheter for only 1 day. These results suggest that 
bladder irritation occurred as a result of the presence of the 
double-J ureteral stent. 
　Ideally, patients should undergo cystoscopy following 
placement of an indwelling, double-J ureteral stent and 
then also after the stent has been removed. However, this 
procedure is burdensome for patients. According to 
Hollenbeck et al, because of the additonal mechanical ma-
neuvers required to remove the ureteral stent, patients 
might suffer injuries to the urinary tract, such as the ure-
thra and bladder [13]. Kim et al evaluated pain that oc-
curred on cystoscopy following an intramuscular injection 
of diclofenac 90 mg [14]. According to these authors, the 
mean VAS score during the procedure was 7.8±0.7 points, 
which indicated severe pain. In addition, only 22.5% of pa-
tients responded “Yes” to a questionnaire about their will-
ingness to submit to the same procedure again. In our ser-
ies, the mean score of the severity of pain was also found 
to be 4.96±1.29 points during removal of the double-J ure-
teral stent; this corresponded to a moderate severity of 
pain.
　Controversy exists regarding the necessity of leaving a 
conventional type of ureteral stent indwelling following 
URS because of the problems caused by the long-term 
placement of the stent. Denstedt et al equally divided 58 
patients who underwent URS into two groups: a ureteral 
stent-indwelling group (n=29) and a non-ureteral-stent- 
indwelling group (n=29) [15]. These authors reported that 
there were no significant differences in complications or 
the success rates of ureteral stone removal between the two 
groups. This finding implies that indwelling ureteral 
stents are not necessary when URS is performed without 
ureteral opening dilation. Through a systemic review and 
meta-analysis, Nabi et al compared the outcomes of pa-
tients both with and without stenting after uncomplicated 
ureteroscopy. They concluded  t h a t  t h e r e  w e r e  n o  s i g -
nificant differences in postoperative requirements for an-
algesia, urinary tract infection, the stone-free rate, or ure-
teric stricture formation [16]. However, Djaladat et al re-
ported that when ureteroscopy was performed without 
catheterization, flank pain and renal colic can result from 
early ureteral edema; in this study, having a ureteral cath-
eter for the first 24 h seemed to eliminate the possibility 
of early ureteral edema, secondary hydronephrosis, and 
pain [7].
Because of the possibility of flank pain or renal colic, 
which could arise from early ureteral edema after URS, we 
did not perform surgery without ureteral stenting.
　Four patients (15.4%) in group 1 experienced flank pain 
of such severity that they required intravenous analgesics. 
This flank pain was also seen in five patients (17.9%) of 
group 2. These results indicate that there was no sig-
nificant difference in the rate of intravenous analgesic use 
between the two groups. In addition, there were no sig-
nificant differences in the types and amounts of analgesics 
used in the current study.
　When we asked our patients the following question: “Are 
you willing to undergo the same surgery if you experience 
ureteral stones again?”, 23 patients in group 1 and 17 pa-
tients in group 2 responded “Yes.” Thus, the possibility that 
the same surgical procedure might be performed again was 
88.5% and 60.7%, respectively. This implied that patients 
left with an indwelling ureteral catheter for 1 day following 
URS had greater compliance than did patients who re-
ceived conventional double-J ureteral stent placement.
　The limitations of the current study are that the sample 
size was small; the study focused on lower ureteral stones 
only; the study did not account for the skill of the surgeons; 
and the study compared only the patients’ subjective pain 
scores.
　The current study is significant, however, because no 
other Korean studies thus far have examined the period of 
ureteral stenting following URS. Further studies are 
therefore warranted to examine ureteral stones at various Korean J Urol 2011;52:698-702
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locations in a larger sample of patients.
 CONCLUSIONS
In patients with lower ureter stones, no ureteral orifice 
stricture, no need for ureteral balloon dilation, and no mu-
cosal injury during surgery, a 1-day indwelling period for 
a ureteral catheter following URS may reduce discomfort 
more than a double-J ureteral stent left indwelling for 2 
weeks. In the present study, there were no significant dif-
ferences in the incidences of postoperative complications 
between the two groups. 
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